Walleye Capital LLC Has $3.84 Million Holdings in Maximus, Inc. (NYSE:MMS)

Walleye Capital LLC decreased its position in shares of Maximus, Inc. (NYSE:MMS) by 15.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,370 shares of the health services provider’s stock after selling 9,469 shares during the quarter. Walleye Capital LLC owned approximately 0.09% of Maximus worth $3,835,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of MMS. UMB Bank n.a. grew its stake in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank acquired a new position in Maximus during the 4th quarter worth about $29,000. V Square Quantitative Management LLC grew its position in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after buying an additional 180 shares during the last quarter. R Squared Ltd acquired a new stake in shares of Maximus in the fourth quarter valued at about $54,000. Finally, IFP Advisors Inc raised its position in shares of Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after acquiring an additional 302 shares during the last quarter. Institutional investors own 97.21% of the company’s stock.

Maximus Trading Down 1.0 %

NYSE MMS opened at $67.39 on Thursday. The stock has a market capitalization of $3.81 billion, a P/E ratio of 14.49 and a beta of 0.68. The business has a 50 day simple moving average of $67.66 and a 200 day simple moving average of $75.76. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.97.

Maximus (NYSE:MMS) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 EPS for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.78%. Maximus’s dividend payout ratio (DPR) is presently 25.81%.

Insider Activity

In other news, Director Jan Madsen sold 2,439 shares of the company’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company’s stock, valued at $1,225,347.87. This represents a 11.88 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of Maximus stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the sale, the insider now directly owns 2,512 shares of the company’s stock, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

MMS has been the topic of several analyst reports. StockNews.com cut Maximus from a “buy” rating to a “hold” rating in a report on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.